Award details

The role of apoptosis in mammary tissue regression

ReferenceBB/C006836/1
Principal Investigator / Supervisor Professor Richard Clarkson
Co-Investigators /
Co-Supervisors
Dr Cristin PRINT
Institution Cardiff University
DepartmentSchool of Biosciences
Funding typeResearch
Value (£) 292,854
StatusCompleted
TypeResearch Grant
Start date 01/10/2005
End date 31/10/2008
Duration37 months

Abstract

Apoptosis is essential for the efficient removal of superfluous cells during development and tissue morphogenesis. This is most evident in example of physiological tissue regression such as involution of the post-lactational mammary gland. In this study we address the possibility that physiological apoptosis has an additional role in regressing tissues, namely that apoptotic cells emit instructions to the surrounding tissue that initiate remodelling. Our first objective is to generate a conditional transgenic mouse line expressing an inhibitor of the core apoptosis machinery. This inhibitor, DQMB-CrmA, will be targeted to epithelial cells of the mammary gland using the MMTV promoter and will be expressed specifically during involution using the rtTA TetO tetracycline inducible system. Histological, molecular and transcriptome analysis of involuting mammary glands in these mutant mice will determine the extent of tissue regression in the absence of apoptosis. To further define the kinetics of this process, apoptosis will be inhibited both at the onset of involution and at the first signs of tissue remodelling (around 60hrs after weaning). We have previously hypothesised that two forms of apoptosis occur in mammary involution, the first example of differential use of apoptosis mechanisms in a physiological regression. Our second objective is to test this hypothesis by generating two additional transgenic lines expressing an inhibitor of extrinsic apoptosis (wtCrmA) and an inhibitor of intrinsic apoptosis (Bcl2), using the MMTV-rtTA system described above. We will study the rate of apoptosis, extent of restructuring and expression of remodelling-associated genes in these mutant mammary glands. The purpose of post-lactational involution of mammary gland is to remove superfluous secretary epithelial cells. Apoptosis clearly plays an important role in this process and our third objective is to assess the long-term consequences of inhibiting apoptosis. We will use the DQMB-CrmA transgenic line to persistently inhibit apoptosis throughout involution, and then we will study the development of the mammary gland during a subsequent pregnancy. Histological and molecular analysis of the mammary glands will determine whether appropriate ductal morphogenesis and alveolar differentiation has occurred. The generation of these transgenic lines will be a valuable resource both for further studies of the role of apoptosis in early mammary development and to the wider apoptosis community.

Summary

unavailable
Committee Closed Committee - Animal Sciences (AS)
Research TopicsAgeing
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file